Tag Archives: NICE Technology Appraisal Guidance: TA217

Assessment and Treatment of Dementia in Older Adults (NICE Eyes on Evidence)

Summary A quick review of the latest evidence regarding the assessment and treatment of dementia in older adults. This systematic review indicates that brief cognitive assessment tools can adequately detect early dementia. Whether interventions for mild cognitive impairment or early dementia … Continue reading

Posted in Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Models of Dementia Care, NICE Guidelines, Non-Pharmacological Treatments, Patient Care Pathway, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Dementia Awareness Week: Thinking Ahead (UKMi)

Summary This edition of Thinking Ahead, from UK Medicines Information  (UKMi), has been written for Dementia Awareness Week May 19th – 25th 2013. Full Text Link (MS Word format). Reference Hall, J. (2013). Thinking Ahead: Worrying changes nothing. Talking changes everything. … Continue reading

Posted in Alzheimer's Society, Antipsychotics, Charitable Bodies, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, Patient Information, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, Standards, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Support for Commissioners of Dementia Care (NICE)

Summary The National Institute for Health and Care Excellence (NICE) has issued a guide to support commissioners, clinicians and managers in the commissioning of high-quality evidence-based care for people with dementia and their carers. The NICE support for commissioning dementia … Continue reading

Posted in Commissioning, Community Care, Diagnosis, End of Life Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NICE Guidelines, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Personalisation, Practical Advice, Quick Insights, Standards, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Update to Dementia on Clinical Knowledge Summaries (Prodigy, formerly CKS)

Summary The Prodigy (formerly Clinical Knowledge Summaries, CKS) topic on Dementia has been updated to include prescribing information for Memantine (Memantine Hydrochloride). Sub-topics comprise: Contraindications. Dose and Titration. Adverse Effects. Drug Interactions. The Basis of Recommendation has been updated to … Continue reading

Posted in For Doctors (mostly), Guidelines, Management of Condition, National, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, UK | Tagged , , , , , , , , , , , | Leave a comment

Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (NICE)

[A version of this abstract appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 1 Issue 9, April 2011]. Abstract Note: The long-awaited review and re-appraisal of Donepezil, Galantamine, Rivastigmine and Memantine for the treatment of Alzheimer’s Disease has resulted in changes to … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, Management of Condition, National, NICE Guidelines, Pharmacological Treatments, Practical Advice, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , | Leave a comment